Multi-Center Study Validates Safety and Efficacy of Senhance Robotic System in Colorectal Surgery
Key Insights
A comprehensive analysis of 355 robotic-assisted colorectal surgeries across two European centers demonstrates the safety and feasibility of the Senhance Robotic System (search), with only 2.9% requiring conversions.
The study revealed efficient surgical metrics, with median operation duration of 147.2 minutes and minimal blood loss in 71.8% of cases, while showing improved performance with increased caseload.
Of 24 reported adverse events, 95.8% were unrelated to the robotic system, with no procedure-related mortalities, establishing a strong safety profile for robotic-assisted colorectal procedures.
A new multi-center study published in the Journal of Robotic Surgery has demonstrated positive outcomes for robotic-assisted colorectal surgery using the Senhance Robotic System (search), marking a significant advancement in minimally invasive surgical techniques.
The comprehensive analysis, conducted across two European centers - Klaipeda University Hospital (search) in Lithuania and Evangelisches Hospital (search) in Germany - evaluated 355 robotic-assisted colorectal procedures, providing robust evidence for the technology's safety and efficacy.
Surgical Procedures and Patient Demographics
The study encompassed three main types of colorectal surgeries: sigmoid resections (47.6% of cases), rectal surgery (34.7%), and right hemicolectomy (17.7%). The patient cohort had a mean age of 64.8 years, with women comprising 56.9% of the population. Notably, 37.7% of participants presented with relevant comorbidities.
Operational Performance Metrics
The surgical procedures demonstrated impressive efficiency metrics:
- Median surgery duration: 147.2 minutes (IQR 124.3-183.0)
- Mean console time: 83.4 minutes
- Median docking time: 3.4 minutes
- Minimal blood loss achieved in 71.8% of cases
A notable finding was the correlation between caseload and improved performance. The Wesel center, with 192 cases, achieved shorter median surgery duration (132 minutes) compared to Klaipeda's 165 minutes across 163 cases. Similarly, docking times were reduced at the higher-volume center.
Safety Profile and Clinical Outcomes
The study's safety data proved particularly compelling:
- Zero procedure-related mortalities
- Only 2.9% conversion rate to traditional surgical methods
- 24 documented intra- and postoperative adverse events
- 95.8% of adverse events were unrelated to the robotic system
The reported complications included hemorrhage, hernia, postoperative ileus, anastomotic leakage, stenosis, and urinary retention. Of these, only five cases were classified as severe, with one event possibly linked to the robotic system.
Technological Implementation
The surgical setup utilized three robotic arms and five trocar placements, standardized across procedures. The Senhance system, developed by Asensus Surgical in Durham, North Carolina, represents FDA-approved technology specifically designed for minimally invasive procedures.
Clinical Implications
While the study noted a limitation regarding patient selection at the Klaipeda center, which may have favored lower-risk candidates, the overall findings strongly support the integration of robotic assistance in colorectal surgery. The data suggests that with proper training and increased experience, surgical teams can achieve efficient and safe outcomes using robotic systems.
The research provides valuable insights for healthcare institutions considering the adoption of robotic surgical systems, particularly for colorectal procedures. The demonstrated safety profile and operational efficiency metrics offer compelling evidence for the continued expansion of robotic-assisted surgical techniques in colorectal surgery.